DOW:NYSEDow Inc. Analysis
Data as of 2026-03-29 - not real-time
$40.82
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Dow Inc. is trading well above its short‑ and medium‑term moving averages, confirming a bullish technical backdrop, while the MACD remains in a bullish configuration. However, the RSI has surged into overbought territory, and trading volume has been on a downtrend, suggesting short‑term momentum may be waning.
The company’s fundamentals are under pressure: revenue is contracting, margins are negative, and free cash flow is negative despite a solid cash balance. The forward earnings outlook is modestly positive, but the forward PE is elevated, and the balance sheet is heavily leveraged with a debt‑to‑equity ratio well above industry norms. Nevertheless, the dividend yield remains attractive, and recent analyst upgrades have injected optimism into the market, driving a noticeable price rally.
The company’s fundamentals are under pressure: revenue is contracting, margins are negative, and free cash flow is negative despite a solid cash balance. The forward earnings outlook is modestly positive, but the forward PE is elevated, and the balance sheet is heavily leveraged with a debt‑to‑equity ratio well above industry norms. Nevertheless, the dividend yield remains attractive, and recent analyst upgrades have injected optimism into the market, driving a noticeable price rally.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish price above key SMAs and bullish MACD
- Recent analyst upgrades and dividend appeal
- Overbought RSI and declining volume raise caution
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Weak earnings and negative cash flow
- High leverage and volatile price swings
- Attractive dividend yield but sustainability concerns
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Fundamental challenges with declining revenue and margins
- Potential for dividend erosion if cash generation does not improve
- Long‑term sector exposure to regulatory and commodity price cycles
Key Metrics & Analysis
Financial Health
Revenue Growth-9.10%
Profit Margin-6.56%
P/E Ratio37.3
ROE-13.82%
ROA-0.07%
Debt/Equity111.87
P/B Ratio1.8
Op. Cash Flow$1.0B
Free Cash Flow$-784750016
Technical Analysis
TrendBullish
RSI73.2
Support$29.39
Resistance$41.06
MA 20$35.82
MA 50$32.36
MA 200$26.43
MACDBullish
VolumeDecreasing
Fear & Greed Index65.98
Valuation
Target Price$36.63
Upside/Downside-10.28%
GradeOvervalued
TypeValue
Dividend Yield4.29%
Risk Assessment
Beta1.42
Volatility47.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.